Related Experiment Video
Updated: Feb 5, 2026

Ex Vivo Infection of Live Tissue with Oncolytic Viruses
Published on: June 25, 2011
Defects in interferon pathways as potential biomarkers of sensitivity to oncolytic viruses
Olga V Matveeva1, Peter M Chumakov2,3
1Biopolymer Design LLC, Acton, MA, USA.
Abstract:
Increased sensitivity of cancer cells to viruses is a prerequisite for the success of oncolytic virotherapy. One of the major causes of such a phenotype is the disruption of innate antiviral defenses associated with dysfunction of type 1 interferons (IFNs) that permits unlimited replication of viruses in cancer cells. Defects in IFN pathways help cancer progression by providing additional advantages to tumor cells. However, while these defects promote the survival and accelerated proliferation of malignant cells, they facilitate viral replication and thus enhance the efficiency of viral oncolysis. This review describes a broad spectrum of defects in genes that participate in IFN induction and IFN response pathways. Expression levels and/or functional activities of these genes are frequently low or absent in cancer cells, making them sensitive to virus infection. Therefore, certain specific defects in IFN signaling cascades might serve as potential biomarkers to help in identifying individual cancer patients who are likely to benefit from oncolytic virotherapy.
Insights
Cancer cells with faulty type 1 interferon (IFN) pathways are more sensitive to viruses, enhancing oncolytic virotherapy. These defects may identify patients who can benefit from this cancer treatment.
Area of Science:
- Oncology
- Virology
- Immunology
Background:
- Oncolytic virotherapy relies on cancer cells' increased sensitivity to viruses.
- Dysfunctional innate antiviral defenses, particularly type 1 interferons (IFNs), contribute to this sensitivity.
- Defects in IFN pathways can paradoxically aid tumor progression while enhancing viral oncolysis.
Purpose of the Study:
- To review defects in genes involved in type 1 interferon induction and response pathways in cancer cells.
- To explore the link between IFN pathway dysfunction and cancer cell sensitivity to viruses.
- To identify potential biomarkers for patient selection in oncolytic virotherapy.
Main Methods:
- Literature review of studies investigating gene defects in IFN pathways.
- Analysis of expression levels and functional activities of IFN-related genes in cancer cells.
- Correlation of IFN pathway status with cancer cell permissiveness to viral infection.
Main Results:
- Cancer cells often exhibit low or absent expression/activity of genes crucial for IFN induction and response.
- These genetic defects lead to impaired innate antiviral defenses, permitting viral replication.
- Such defects enhance the efficiency of oncolytic virotherapy by increasing viral permissiveness.
Conclusions:
- Specific defects in IFN signaling pathways are common in cancer cells.
- These defects render cancer cells susceptible to oncolytic viruses.
- Identifying these IFN pathway defects could serve as biomarkers to select patients for oncolytic virotherapy.
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
What are Viruses?
Lumber Defects
Shakes are minor fractures that run along or across the wood's annual rings, while wane is...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Standard Electrode Potentials

